Applied BioCode Corporation (TPE:6598)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.35
-0.20 (-0.85%)
At close: Mar 27, 2026

Applied BioCode Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
475.2343.07395.17390.3319.96
Revenue Growth (YoY)
38.52%-13.18%1.25%21.98%7.00%
Cost of Revenue
214.31139.07126.43156.13130.6
Gross Profit
260.89204268.74234.17189.37
Selling, General & Admin
185.13209.05209.15188.04148.46
Research & Development
298.59272.62246.01238.37205.85
Operating Expenses
484.23481.91455.44426.77354.31
Operating Income
-223.33-277.91-186.7-192.6-164.94
Interest Expense
-1.59-1.43-2.17-2.78-2.87
Interest & Investment Income
22.9427.6323.968.513.11
Currency Exchange Gain (Loss)
--2.35-0.311.22-0
Other Non Operating Income (Expenses)
0.860.160.010.95-0.46
EBT Excluding Unusual Items
-201.12-253.9-165.21-184.71-165.17
Gain (Loss) on Sale of Assets
---0.92--0.01
Legal Settlements
--6.88---
Pretax Income
-201.12-260.78-163.44-184.71-165.18
Income Tax Expense
0.080.030.760.020.02
Net Income
-201.2-260.81-164.2-184.73-165.2
Net Income to Common
-201.2-260.81-164.2-184.73-165.2
Shares Outstanding (Basic)
10391828282
Shares Outstanding (Diluted)
10391828282
Shares Change (YoY)
13.29%10.82%0.01%0.07%5.33%
EPS (Basic)
-1.96-2.88-2.01-2.26-2.02
EPS (Diluted)
-1.96-2.88-2.01-2.26-2.02
Free Cash Flow
-235.46-215.12-211.48123.73-167.29
Free Cash Flow Per Share
-2.29-2.37-2.591.51-2.05
Gross Margin
54.90%59.46%68.01%60.00%59.18%
Operating Margin
-47.00%-81.01%-47.25%-49.35%-51.55%
Profit Margin
-42.34%-76.02%-41.55%-47.33%-51.63%
Free Cash Flow Margin
-49.55%-62.70%-53.52%31.70%-52.29%
EBITDA
-166.96-231.33-139.2-151.85-128
EBITDA Margin
-35.13%-67.43%-35.23%-38.91%-40.01%
D&A For EBITDA
56.3846.5847.540.7536.94
EBIT
-223.33-277.91-186.7-192.6-164.94
EBIT Margin
-47.00%-81.01%-47.25%-49.35%-51.55%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.